Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160938 · ClinicalTrials.gov registry record
Prenatal Microarray Follow-Up Study
A clinical trial, sponsored by Columbia University.
- Completed
- Registry status
- 184
- Enrollment target
NCT02160938: Completed study, sponsored by Columbia University.
NCT02160938 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 184 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02160938 has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 184 participants
- Enrollment target
Study Summary
The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.
Primary Outcome
Full Scale IQ score from the Wechsler Preschool and Primary Scale of Intelligence IV or Wechsler Intelligence Scale for Children 5th edition
Interventions
- OTHER 3-year follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2013-02 |
| Est. Completion | 2018-12 |
What the finished NCT02160938 record still lists
NCT02160938 is an observational study that tracks outcomes without assigning an intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which 3-year follow-up is the first listed.
NCT02160938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02160938 about?
NCT02160938 is a clinical study titled "Prenatal Microarray Follow-Up Study". The objectives of this multi-center collaborative study are to ascertain the frequency of specific copy number variants (CNVs) identified prenatally and to evaluate in detail through continued follow-up of the children the phenotypes associated with CNVs of known or uncertain clinical significance.
What is the current status of trial NCT02160938?
This trial is currently completed. The enrollment target is 184 participants. The study started on 2013-02. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02160938?
The interventions under investigation include: 3-year follow-up (OTHER).
Who is sponsoring clinical trial NCT02160938?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia